Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study
Creatinine-based estimated glomerular filtration rate (eGFR) determines chronic kidney disease (CKD) stage, but underestimates renal function. The 2014 updated guidance from the National Institute for Health and Care Excellence (NICE) recommends that GPs reduce overdiagnosis of CKD stage 3a (eGFR 45...
Auteurs principaux: | Lasserson, D, Shine, B, O'Callaghan, C, James, T |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Royal College of General Practitioners
2017
|
Documents similaires
-
Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
par: O'Callaghan, C, et autres
Publié: (2011) -
Cystatin C proteoforms in chronic kidney disease.
par: Helene Dahl, et autres
Publié: (2023-01-01) -
Cystatin C proteoforms in chronic kidney disease
par: Helene Dahl, et autres
Publié: (2023-01-01) -
Chronic kidney disease--assessing the impact.
par: O'Callaghan, C
Publié: (2009) -
Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients
par: Marlene Tapper, et autres
Publié: (2021-01-01)